Characterization of international partnerships in global retinoblastoma care and research: A network analysis
Related Experiment Video
Updated: Jun 27, 2026

Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
Published on: August 4, 2011
Hannah Girdler1, Kaitlyn Flegg2, John Prochaska3
1Human Biology Program, Faculty of Arts & Science, University of Toronto, Toronto, Canada.
Insights
Global cooperation in retinoblastoma research is extensive, with most collaborations focusing on patient referrals and capacity building. Expanding network peripheries can further reduce global retinoblastoma mortality.
Area of Science:
- Global Health
- Ophthalmology
- Cancer Research
Background:
- Global cooperation is crucial for advancing global health research and practice.
- Retinoblastoma, a pediatric eye cancer, necessitates international collaboration for effective treatment and outcomes.
- The One Retinoblastoma World (1RBW) network facilitates global efforts in retinoblastoma care.
Purpose of the Study:
- To quantify and characterize collaborations within the 1RBW network.
- To understand the perceived contributions of these collaborations to improving retinoblastoma outcomes.
- To identify facilitators and barriers to effective global partnerships in retinoblastoma care.
Main Methods:
- A cross-sectional, mixed-methods egocentric network analysis was employed.
- 170 1RBW treatment centers were invited to complete an electronic survey.
- 18 key informants participated in semi-structured interviews for qualitative insights.
Main Results:
- 56% of centers completed the survey, identifying 112 unique collaborating partners (80 treatment centers, 32 other organizations).
- The network comprised 168 nodes, with primary collaborations in patient referrals, consultations, and capacity building.
- Qualitative analysis revealed themes on partnership conceptualization, motivations, challenges, and benefits.
Conclusions:
- Extensive global collaboration exists to reduce retinoblastoma mortality.
- Opportunities remain to enhance network connectivity by engaging peripheral actors.
- Strengthening global partnerships is key to improving outcomes for children with retinoblastoma worldwide.
Abstract:
Global cooperation is an integral component of global health research and practice. One Retinoblastoma World (1RBW) is a cooperative network of global treatment centers that care for children affected by retinoblastoma. The study aimed to determine the number, scope and nature of collaborations within 1RBW, and uncover how they are perceived to contribute towards improving retinoblastoma outcomes. A cross-sectional, mixed-methods egocentric network analysis was conducted. Treatment centers (n = 170) were invited to complete an electronic survey to identify collaborative activities between their institution (ego), and respective partners (alters). Network maps were generated to visualize connectivity. Key informants (n = 18) participated in semi-structured interviews to add details about the reported collaborations. Interviews were analysed through inductive thematic analysis. Surveys were completed by 56/170 (33%) of 1RBW treatment centers. Collectively, they identified 112 unique alters (80 treatment centers; 32 other organizations) for a total network size of 168 nodes. Most collaborations involved patient referrals, consultations and twinning/capacity building. Interviews identified four main themes: conceptualization of partnership; primary motivation for collaborations; common challenges to collaboration; and benefits to partnership. There is extensive global collaboration to reduce global retinoblastoma mortality, but there is room to expand connectivity through active efforts to include actors located at network peripheries.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

